Skip to main content

Movers & Shakers: Apr 15, 2011

Premium

The Critical Path Institute is searching for a new CEO. Recently, C-Path Institute Founder Raymond Woosley said he would step down as president/CEO of the institute in January 2012 or as soon as the position had been filled.

A search committee formed by C-Path's board of directors said this week that it is actively looking for Woosley's replacement. The new leader will be tasked with working collaboratively with regulatory and industry leaders to advance research and speed the introduction of innovative treatments to market.

C-Path is asking its collaborators and consortia members to recommend candidates for the position. People interested in applying for this position should send a letter of interest, CV, and three references to searchcommittee [at] c-path [.] org.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.